Primary Site >> Colorectal Cancer
Gene >> CD59
| 1. | |||||||||||
| Journal: | Br J Cancer. 1993 Nov;68(5):926-31. | ||||||||||
| Title: | Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium. | ||||||||||
| Author: | Koretz, K|Bruderlein, S|Henne, C|Moller, P | ||||||||||
| PMID: | 7692919 | ||||||||||
| 2. | |||||||||||
| Journal: | Acta Med Okayama. 1994 Oct;48(5):271-7. | ||||||||||
| Title: | Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer. | ||||||||||
| Author: | Inoue, H|Mizuno, M|Uesu, T|Ueki, T|Tsuji, T | ||||||||||
| PMID: | 7532345 | ||||||||||
| 3. | |||||||||||
| Journal: | Scand J Immunol. 1995 Nov;42(5):512-6. | ||||||||||
| Title: | Down-regulation of CD59 (protectin) expression on human colorectal adenocarcinoma cell lines by levamisole. | ||||||||||
| Author: | Bjorge, L|Matre, R | ||||||||||
| PMID: | 7481554 | ||||||||||
| 4. | |||||||||||
| Journal: | Am J Pathol. 1996 Jul;149(1):129-42. | ||||||||||
| Title: | Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). | ||||||||||
| Author: | Niehans, G A|Cherwitz, D L|Staley, N A|Knapp, D J|Dalmasso, A P | ||||||||||
| PMID: | 8686736 | ||||||||||
| 5. | |||||||||||
| Journal: | APMIS. 1998 Sep;106(9):869-78. | ||||||||||
| Title: | The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues. | ||||||||||
| Author: | Thorsteinsson, L|O'Dowd, G M|Harrington, P M|Johnson, P M | ||||||||||
| PMID: | 9808413 | ||||||||||
| 6. | |||||||||||
| Journal: | Eur J Cancer. 1999 Jan;35(1):117-24. | ||||||||||
| Title: | Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours. | ||||||||||
| Author: | Schmitt, C A|Schwaeble, W|Wittig, B M|Meyer zum Buschenfelde, K H|Dippold, W G | ||||||||||
| PMID: | 10211099 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Res. 2001 Jan 15;61(2):654-8. | ||||||||||
| Title: | Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancer. | ||||||||||
| Author: | Chen, R|Eshleman, J R|Brodsky, R A|Medof, M E | ||||||||||
| PMID: | 11212264 | ||||||||||
| 8. | |||||||||||
| Journal: | Curr Opin Investig Drugs. 2001 Jul;2(7):959-66. | ||||||||||
| Title: | Immunization against tumor cell surface complement-regulatory proteins. | ||||||||||
| Author: | Durrant, L G|Spendlove, I | ||||||||||
| PMID: | 11757799 | ||||||||||
| 9. | |||||||||||
| Journal: | J Gastrointest Surg. 2001 Nov-Dec;5(6):673-9. | ||||||||||
| Title: | Expression of 17-1A antigen and complement resistance factors CD55 and CD59 on liver metastasis in colorectal cancer. | ||||||||||
| Author: | Hosch, S B|Scheunemann, P|Luth, M|Inndorf, S|Stoecklein, N H|Erbersdobler, A|Rehders, A|Gundlach, M|Knoefel, W T|Izbicki, J R | ||||||||||
| PMID: | 12086907 | ||||||||||
| 10. | |||||||||||
| Journal: | Mol Immunol. 2003 Sep;40(1):13-23. | ||||||||||
| Title: | Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model. | ||||||||||
| Author: | Gelderman, K A|Hakulinen, J|Hagenaars, M|Kuppen, P J K|Meri, S|Gorter, A | ||||||||||
| PMID: | 12909127 | ||||||||||
| 11. | |||||||||||
| Journal: | Clin Cancer Res. 2004 Apr 15;10(8):2797-803. | ||||||||||
| Title: | Loss of CD55 is associated with aggressive breast tumors. | ||||||||||
| Author: | Madjd, Zahra|Durrant, Lindy G|Bradley, Richard|Spendlove, Ian|Ellis, Ian O|Pinder, Sarah E | ||||||||||
| PMID: | 15102687 | ||||||||||
| 12. | |||||||||||
| Journal: | Cancer Immunol Immunother. 2006 Aug;55(8):973-80. Epub 2005 Sep 3. | ||||||||||
| Title: | Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients. | ||||||||||
| Author: | Watson, Nicholas F S|Durrant, Lindy G|Madjd, Zahra|Ellis, Ian O|Scholefield, John H|Spendlove, Ian | ||||||||||
| PMID: | 16151805 | ||||||||||
| 13. | |||||||||||
| Journal: | Exp Mol Pathol. 2006 Aug;81(1):77-84. Epub 2005 Dec 27. | ||||||||||
| Title: | Dexamethasone modifies the susceptibility to serum cytotoxicity and increases the metastatic efficiency of a colon carcinoma cell line. | ||||||||||
| Author: | Yoshida, Yukio|Kishimoto, Takashi|Ishiguro, Hiroshi|Nagai, Yuichiro|Koda, Keiji|Takiguchi, Nobuhiro|Miyazaki, Masaru|Ishikura, Hiroshi | ||||||||||
| PMID: | 16380115 | ||||||||||
| 14. | |||||||||||
| Journal: | Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Feb;103(2):231-9. Epub | ||||||||||
| Title: | Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors. | ||||||||||
| Author: | Ravindranath, Naren M H|Shuler, Charles | ||||||||||
| PMID: | 17234541 | ||||||||||
| 15. | |||||||||||
| Journal: | J Immunol. 2009 May 1;182(9):5203-7. | ||||||||||
| Title: | CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy? | ||||||||||
| Author: | Sivasankar, Baalasubramanian|Longhi, M Paula|Gallagher, Kathleen M E|Betts, Gareth J|Morgan, B Paul|Godkin, Andrew J|Gallimore, Awen M | ||||||||||
| PMID: | 19380765 | ||||||||||
| 16. | |||||||||||
| Journal: | Int J Biol Markers. 2013 Sep 27;28(3):267-73. | ||||||||||
| Title: | Cytometric profiling of CD133+ cells in human colon carcinoma cell lines identifies a common core phenotype and cell type-specific mosaics. | ||||||||||
| Author: | Gemei, Marica|Di Noto, Rosa|Mirabelli, Peppino|Del Vecchio, Luigi | ||||||||||
| PMID: | 23709346 | ||||||||||
| 17. | |||||||||||
| Journal: | Am J Physiol Gastrointest Liver Physiol. 2014 Jun 15;306(12):G1056-64. | ||||||||||
| Title: | CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of alpha-gal xenoantigen in colon tumor cells. | ||||||||||
| Author: | Wu, Yanxia|Wang, Yaogeng|Qin, Feng|Wang, Zhu|Wang, Yu|Yang, Yajun|Zheng, Hong|Wang, Yanping | ||||||||||
| PMID: | 24763553 | ||||||||||
| 18. | |||||||||||
| Journal: | Arch Pathol Lab Med. 2014 Jul;138(7):910-9. | ||||||||||
| Title: | Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer. | ||||||||||
| Author: | Shang, Yulong|Chai, Na|Gu, Yong|Ding, Li|Yang, Yan|Zhou, Jinfeng|Ren, Gui|Hao, Xiaoke|Fan, Daiming|Wu, Kaichun|Nie, Yongzhan | ||||||||||
| PMID: | 24978917 | ||||||||||
| 19. | |||||||||||
| Journal: | J Infect Chemother. 2015 Jan;21(1):8-15. | ||||||||||
| Title: | Silencing of CD59 enhanced the sensitivity of HT29 cells to 5-Fluorouracil and Oxaliplatin. | ||||||||||
| Author: | Yin, Haipeng|Li, Cuiling|Wang, Shaoyu|Guo, Qiang|Ren, Xia|Jiang, Guosheng | ||||||||||
| PMID: | 25444672 | ||||||||||
| 20. | |||||||||||
| Journal: | Oncotarget. 2017 Jan 24;8(4):6819-6832. | ||||||||||
| Title: | Proteins that interact with calgranulin B in the human colon cancer cell line HCT-116. | ||||||||||
| Author: | Myung, Jae Kyung|Yeo, Seung-Gu|Kim, Kyung Hee|Baek, Kwang-Soo|Shin, Daye|Kim, Jong Heon|Cho, Jae Youl|Yoo, Byong Chul | ||||||||||
| PMID: | 28036279 | ||||||||||